Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Guangzhou Medical UniversityNo recent work listed

Xiaofeng Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5483-8111; OpenAlex author ID A5061257236. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case series and literature review Last author DOI 10.21203/rs.3.rs-1969267/v1↗
  2. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer. Co-author DOI 10.1016/j.phrs.2021.105811↗
  3. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote ca… Last author DOI 10.1002/ijc.30278↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bingqing Du · 1 shared paper, 2022 · strength 0.15
  2. Huihong Liang · 1 shared paper, 2022 · strength 0.15
  3. Xuewei Yang · 1 shared paper, 2022 · strength 0.15
  4. Xiaodong Song · 1 shared paper, 2022 · strength 0.15
  5. Zhen Li · 1 shared paper, 2021 · strength 0.12
  6. Mingfeng Bai · 1 shared paper, 2021 · strength 0.12
  7. Dawei Zhang · 1 shared paper, 2021 · strength 0.12
  8. Dawei Guo · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.